STOCK TITAN

Amarin Plc (AMRN) Stock News, Feb-May 2024

AMRN NASDAQ

Amarin Corporation plc develops and commercializes cardiovascular therapeutics centered on icosapent ethyl, marketed as VASCEPA in the United States and VAZKEPA in Europe. Company news commonly covers product revenue, cash flow, U.S. prescription trends, partner-led international commercialization, and European distribution under an exclusive licensing and supply agreement with Recordati.

Updates also include medical-society guideline discussions, REDUCE-IT analyses, peer-reviewed publications, and scientific meeting presentations on cardiovascular risk reduction, elevated triglycerides, eicosapentaenoic acid, and lipoprotein(a) oxidation.

Rhea-AI Summary

Amarin plc (NASDAQ: AMRN) will have their president and CEO, Patrick Holt, participate in a fireside chat at the 2024 H.C. Wainwright 2nd Annual BioConnect Investor Conference on May 20th, 2024, in NYC. The session will be webcast live and archived on the Company’s website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
conferences
-
Rhea-AI Summary

Amarin plc (NASDAQ:AMRN) reported its first-quarter 2024 business update and financial results. The company received a new patent extending intellectual property protection in Europe until 2039. While the U.S. market saw a decline in revenue due to generic competition, the European market experienced significant growth. Amarin also announced a share repurchase program and remains stable with a cash position of $308 million. Overall, the company is focused on enhancing its value for the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.86%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.01%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.90%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.90%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.07%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.94%
Tags

FAQ

What is the current stock price of Amarin (AMRN)?

Amarin (AMRN) last closed at $10.57.

What is the market cap of Amarin (AMRN)?

The market cap of Amarin (AMRN) is approximately $222.7M.